Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POPular CABG
NCT02352402Phase 3Unknown
- Start
- Mar 2015
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in saphenous vein graft occlusion. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
saphenous vein graft occlusion
Beyond the preview
Go deeper on NCT02352402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02352402.